Litigation Details for Amgen Inc. v. Emcure Pharmaceuticals Ltd. (D. Del. 2018)
✉ Email this page to a colleague
Amgen Inc. v. Emcure Pharmaceuticals Ltd. (D. Del. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-09-07 |
Court | District Court, D. Delaware | Date Terminated | 2018-12-06 |
Cause | 35:271 Patent Infringement | Assigned To | Mitchell S. Goldberg |
Jury Demand | None | Referred To | |
Patents | 7,829,595 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Amgen Inc. v. Emcure Pharmaceuticals Ltd.
Details for Amgen Inc. v. Emcure Pharmaceuticals Ltd. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-09-07 | 1 | Complaint | inter alia, the ’405 patent and its parent, U.S. Patent No. 7,829,595 (“the ’595 patent”). …infringement of U.S. Patent No. 9,375,405 (the “’405 patent”) (Exhibit A) under the Patent Laws of the United… THE PATENT-IN-SUIT 15. On June 28, 2016, the ’405 patent, titled “Rapid …United States Patent and Trademark Office (“PTO”). 16. The ’405 patent is assigned to…review pharmaceutical patents and seek opportunities to challenge those patents. 28. | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |